N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain
Neuropathic pain (NP) remains maltreated for a wide number of patients by the currently available treatments and little research has been done in finding new drugs for treating NP. Ziconotide (PrialtTM) had been developed as the new drug, which belongs to the class of ω-conotoxin MVIIA. It inhibits...
Saved in:
Main Authors: | Shikha Choudhary (Author), Raminderjit Kaur (Author), Aafrin Waziri (Author), Arun Garg (Author), Renu Kadian (Author), Md Sabir Alam (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calcium Channel Blocker Overdose Simulation
by: Michael Maniaci, et al.
Published: (2015) -
Discovery and Development of Calcium Channel Blockers
by: Théophile Godfraind
Published: (2017) -
T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
by: Maricruz Rangel-Galván, et al.
Published: (2023) -
Are calcium channel blockers related to lung cancer?
by: Ratchanon Rattanathanoo, et al.
Published: (2023) -
Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes
by: Jonathan W. Theile, et al.
Published: (2011)